SCHIZOPHRENIA 1 (Disorder): Clinical Trials

2 trials for SCHIZOPHRENIA 1 (Disorder), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1
Phase 21Recruiting 1

Follow SCHIZOPHRENIA 1 (Disorder): new trials by email Literature Review of SCHIZOPHRENIA 1 (Disorder) trials Research Report on SCHIZOPHRENIA 1 (Disorder)

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
Xanomeline and trospium chloride (KarXT) - SCHIZOPHRENIA 1 (Disorder), Schizoaffecitve Disorder
Phase 1 / Phase 2RecruitingNew York State Psychiatric Institute122026-07-012026-07-14
Bioequivalence Study to Compare Cariprazine 1.5 mg Hard Capsules (1.5 mg Cariprazine Hydrochloride) Versus Reagila® 1,5 mg Hartkapseln (Hard Capsules) (Cariprazine)
Cariprazine Hard Capsules, Reagila® Hartkapseln (Hard Capsules) (Cariprazine) - SCHIZOPHRENIA 1 (Disorder)
Phase 1CompletedHumanis Saglık Anonim Sirketi322026-03-052026-07-08

Interventions

cariprazine (1)  ·  trospium chloride (1)  ·  xanomeline (1)

Sponsors

Humanis Saglık Anonim Sirketi (1)  ·  New York State Psychiatric Institute (1)

Countries

India (1)  ·  United States (1)

Top investigators

Joshua T Kantrowitz, MD (1)  ·  Ragy Girgis, MD (1)